Larimar Therapeutics Inc
Stock Chart, Company Information, and Scan Results
$5.95(as of Feb 25, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Larimar Therapeutics Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$5.95
Ticker SymbolLRMR
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees65
CountyUSA
Market Cap$315.8M
EBIDTA-139.4M
P/E Ratio-3.53
Forward P/E Ratio0.00
Earnings per Share-1.96
Profit Margin-Infinity%
RSI79.91
Shares Outstanding83.1M
ATR0.47
52-Week High6.42
Volume80,728,615
52-Week Low1.61
Book Value139.0M
P/B Ratio3.35
Upper Keltner4.48
P/S Ratio966.87
Lower Keltner2.36
Next Earnings Date03/18/2026
Cash Surplus45.0M
Next Ex-Dividend DateUnknown
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
Larimar Therapeutics Inc In Our Stock Scanner
As of Feb 26, 2026
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---
Scan Name: Most Volatile StocksScan Type: Stock Indicator Scans
As of ---
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.